Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Wargo

Showing results (1-10 of 312) with videos related to

Pageof 32
Sort By:
Science (New York, N.Y.)|September 11, 2020
Modulating gut microbesJennifer A Wargo
Cell Reports. Medicine|January 14, 2022
More fuel for the fire: Gut microbes and toxicity to immune agonist antibodies in cancerManoj Chelvanambi, Jennifer A Wargo
Nature Reviews. Clinical Oncology|April 22, 2022
Gut microbes as biomarkers of ICI response - sharpening the focusNeal Bhutiani, Jennifer A Wargo
The Lancet. Oncology|June 8, 2019
Neoadjuvant therapy for melanoma: is it ready for prime time?Beth Helmink, Jennifer A Wargo
Hematology/Oncology Clinics of North America|May 26, 2009
Surgical management of melanomaJennifer A Wargo, Kenneth Tanabe
Trends in Immunology|July 14, 2023
MAdCAM-1: a newly identified microbial 'gut check' for T cellsManoj Chelvanambi, Jennifer A Wargo
Med (New York, N.Y.)|May 18, 2022
Trust your gut when it comes to driving CARsManoj Chelvanambi, Jennifer A Wargo
Advances in Surgery|December 6, 2002
The status of gene therapy for surgical diseaseJennifer A Wargo, James S Economou
Surgical Oncology Clinics of North America|May 14, 2019
The Current Landscape of Immune Checkpoint Inhibition for Solid MalignanciesEmily Z Keung, Jennifer A Wargo
Trends in Immunology|November 27, 2024
Engineering immunity: bacterial delivery of cancer neoantigen vaccinesChristopher D Johnston, Jennifer A Wargo
Pageof 32

Showing results (1-10 of 312) with videos related to

Sort By:
Pageof 32
Science (New York, N.Y.)|September 11, 2020
Modulating gut microbesJennifer A Wargo
Cell Reports. Medicine|January 14, 2022
More fuel for the fire: Gut microbes and toxicity to immune agonist antibodies in cancerManoj Chelvanambi, Jennifer A Wargo
Nature Reviews. Clinical Oncology|April 22, 2022
Gut microbes as biomarkers of ICI response - sharpening the focusNeal Bhutiani, Jennifer A Wargo
The Lancet. Oncology|June 8, 2019
Neoadjuvant therapy for melanoma: is it ready for prime time?Beth Helmink, Jennifer A Wargo
Hematology/Oncology Clinics of North America|May 26, 2009
Surgical management of melanomaJennifer A Wargo, Kenneth Tanabe
Trends in Immunology|July 14, 2023
MAdCAM-1: a newly identified microbial 'gut check' for T cellsManoj Chelvanambi, Jennifer A Wargo
Med (New York, N.Y.)|May 18, 2022
Trust your gut when it comes to driving CARsManoj Chelvanambi, Jennifer A Wargo
Advances in Surgery|December 6, 2002
The status of gene therapy for surgical diseaseJennifer A Wargo, James S Economou
Surgical Oncology Clinics of North America|May 14, 2019
The Current Landscape of Immune Checkpoint Inhibition for Solid MalignanciesEmily Z Keung, Jennifer A Wargo
Trends in Immunology|November 27, 2024
Engineering immunity: bacterial delivery of cancer neoantigen vaccinesChristopher D Johnston, Jennifer A Wargo
Pageof 32